<p><strong>Testing Prior To Initiation Of Tenofovir Alafenamide</strong>: Prior to initiation of Tenofovir Alafenamide, patients should be tested for&nbsp;HIV-1 infection. Tenofovir Alafenamide alone should not be used in patients with HIV infection<br />
<br />
It is recommended that serum creatinine, serum phosphorous, estimated creatinine clearance, urine glucose, and urine protein be assessed before initiating Tenofovir Alafenamide and during therapy in all patients as clinically appropriate<br />
<br />
<strong>Recommended Dosage In Adults</strong>: The recommended dosage of Tenofovir Alafenamide is 25 mg (one tablet) taken orally once daily with food</p>